10X Genomics, Inc. (TXG)
80.62
-17.12
(-17.52%)
USD |
NASDAQ |
Oct 06, 16:00
80.60
-0.02
(-0.02%)
After-Hours: 20:00
10X Genomics Free Cash Flow : 121.44M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 121.44M |
| March 31, 2026 | 122.18M |
| December 31, 2025 | 130.12M |
| September 30, 2025 | 81.65M |
| June 30, 2025 | 56.88M |
| March 31, 2025 | 44.36M |
| December 31, 2024 | -6.729M |
| September 30, 2024 | 25.04M |
| June 30, 2024 | -33.45M |
| March 31, 2024 | -73.95M |
| December 31, 2023 | -64.72M |
| September 30, 2023 | -113.04M |
| June 30, 2023 | -118.44M |
| Date | Value |
|---|---|
| March 31, 2023 | -125.74M |
| December 31, 2022 | -165.27M |
| September 30, 2022 | -161.07M |
| June 30, 2022 | -161.38M |
| March 31, 2022 | -128.64M |
| December 31, 2021 | -122.65M |
| September 30, 2021 | -253.28M |
| June 30, 2021 | -263.78M |
| March 31, 2021 | -288.58M |
| December 31, 2020 | -256.29M |
| September 30, 2020 | -103.73M |
| June 30, 2020 | -45.94M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -93.22M |
| Tempus AI, Inc. | -273.72M |
| Personalis, Inc. | -100.98M |
| Alamar Biosciences, Inc. (California) | -63.24M |
| Beam Therapeutics, Inc. | -372.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 16.97M |
| Cash from Investing (Quarterly) | -7.735M |
| Cash from Financing (Quarterly) | 3.016M |
| Free Cash Flow Per Share (Quarterly) | 0.1184 |
| Free Cash Flow to Equity (Quarterly) | 17.98M |
| Free Cash Flow to Firm (Quarterly) | 15.39M |
| Free Cash Flow Yield | 1.18% |